Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples